Global Drug Discovery Outsourcing Market to Reach $6.6 Billion by 2030
The global market for Drug Discovery Outsourcing estimated at US$4.9 Billion in the year 2022, is projected to reach a revised size of US$6.6 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2022-2030. Lead Identification & Candidate Optimization, one of the segments analyzed in the report, is projected to record 6.1% CAGR and reach US$3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Preclinical Development segment is readjusted to a revised 2.8% CAGR for the next 8-year period.The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 8.9% CAGR
The Drug Discovery Outsourcing market in the U.S. is estimated at US$1.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 8.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at -0.5% and 2.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 0.5% CAGR.Select Competitors (Total 33 Featured) -
- Albany Molecular Research, Inc.
- Aptuit LLC
- Charles River
- Dalton Pharma Services
- DiscoverX Corporation
- Domainex
- EVOTEC
- GenScript
- Jubilant Biosys
- LabCorp
- Merck & Co., Inc.
- Oncodesign
- PPD, Inc.
- QIAGEN
- QuintilesIMS
- Selcia Ltd.
- Sigma-Aldrich Co. LLC
- TGS Lifesciences Pvt Ltd.
- Thermo Fisher Scientific, Inc.
- Viva Biotech Ltd.
- WIL Research
- WuXi AppTec
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Albany Molecular Research, Inc.
- Aptuit LLC
- Charles River
- Dalton Pharma Services
- DiscoverX Corporation
- Domainex
- EVOTEC
- GenScript
- Jubilant Biosys
- LabCorp
- Merck & Co., Inc.
- Oncodesign
- PPD, Inc.
- QIAGEN
- QuintilesIMS
- Selcia Ltd.
- Sigma-Aldrich Co. LLC
- TGS Lifesciences Pvt Ltd.
- Thermo Fisher Scientific, Inc.
- Viva Biotech Ltd.
- WIL Research
- WuXi AppTec
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 89 |
Published | March 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 4.9 Billion |
Forecasted Market Value ( USD | $ 6.6 Billion |
Compound Annual Growth Rate | 3.8% |
Regions Covered | Global |